Ignite Creation Date:
2024-05-06 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05343637
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2022-04-04
Brief Title:
A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension
Sponsor:
Respira Therapeutics Inc
Organization:
Respira Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pulmonary Arterial Hypertension |
Keywords:
| Name | View |
|---|---|
| Molecular Mechanisms of Pharmacological Action | View |
| Pulmonary Arterial Hypertension | View |
| Familial Primary Pulmonary Hypertension | View |
| Vascular Diseases | View |
| Cardiovascular Diseases | View |
| Hypertension Pulmonary | View |
| Lung Diseases | View |
| Respiratory Tract Diseases | View |
| Vardenafil Dihydrochloride | View |
| Vasodilator Agents | View |
| Phosphodiesterase 5 Inhibitors | View |
| Phosphodiesterase Inhibitors | View |
| Enzyme Inhibitors | View |